Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4A | O75164 | 12/20 | 0.64 |
| ▸ | KDM4C | Q9H3R0 | 12/20 | 0.64 |
| ▸ | KDM5A | P29375 | 1/20 | 0.64 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.64 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.64 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | TLR2 | O60603 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6647561 | 0.97 | KDM4A (0.66) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL6029256 | 0.97 | KDM4A (0.68) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL1176587 | 0.97 | KDM4A (0.68) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL219327 | 0.97 | KDM4A (0.68) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL3402761 | 0.97 | KDM4A (0.68) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL5530872 | 0.97 | KDM4A (0.68) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL5219324 | 0.97 | KDM4A (0.68) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL13286331 | 0.97 | KDM4A (0.68) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL8213501 | 0.97 | KDM4A (0.68) | KDM4AKDM4CKDM5AKDM7APHF8 | |
| SCHEMBL28020165 | 0.97 | KDM4A (0.68) | KDM4AKDM4CKDM5AKDM7APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025080945-A1 | LIPID NANOPARTICLES | CodeBridgeBio Inc. (US) | 2025-04-17 | — | — | WO | claimed |
| CN-119233657-A | Perovskite solar cell, preparation method thereof and photovoltaic module | 天合光能股份有限公司 | 2024-12-31 | — | — | CN | claimed |
| WO-2024197404-A1 | BACTERIA-RESPONSIVE PARTICLES, METHODS FOR PREPARATION, AND USE IN PACKAGING OR ON SURFACES | HO EMMANUEL ABRAHAM (CA) | 2024-10-03 | — | — | WO | claimed |
| CN-112707670-B | Cross-linked concrete viscosity regulator and preparation method thereof | 科之杰新材料集团有限公司 | 2022-04-22 | — | — | CN | claimed |
| CN-107208095-B | Compositions and methods for silencing hepatitis b virus gene expression | 阿布特斯生物制药公司 | 2021-11-16 | — | — | CN | claimed |
| EP-3201338-B1 | COMPOSITIONS AND METHODS FOR SILENCING HEPATITIS B VIRUS GENE EXPRESSION | ARBUTUS BIOPHARMA CORP (CA) | 2021-11-03 | — | — | EP | claimed |
| CN-112745459-A | Concrete viscosity regulator and preparation method thereof | 科之杰新材料集团有限公司 | 2021-05-04 | — | — | CN | claimed |
| CN-112707670-A | Cross-linked concrete viscosity regulator and preparation method thereof | 科之杰新材料集团有限公司 | 2021-04-27 | — | — | CN | claimed |
| EP-3558271-A1 | METHODS FOR AMELIORATING INFUSION REACTIONS | Arbutus Biopharma Corporation (CA) | 2019-10-30 | — | — | EP | claimed |
| EP-3500294-A1 | ANTI-PD-1 ANTIBODIES, OR FRAGMENTS THEREOF, FOR TREATING HEPATITIS B | Arbutus Biopharma Corporation (CA) | 2019-06-26 | — | — | EP | claimed |
| WO-2018119115-A1 | METHODS FOR AMELIORATING INFUSION REACTIONS | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2018-06-28 | — | — | WO | claimed |
| WO-2018039131-A1 | ANTI-PD-1 ANTIBODIES, OR FRAGMENTS THEREOF, FOR TREATING HEPATITIS B | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2018-03-01 | — | — | WO | claimed |
| CN-107208095-A | Composition and method for making hepatitis B virogene expression silencing | 普洛体维生物治疗公司 | 2017-09-26 | — | — | CN | claimed |
| EP-2828257-B1 | ANTIBACTERIAL COMPOUNDS | BIOTA EUROPE LTD (GB) | 2017-07-26 | — | — | EP | claimed |
| EP-3033325-A1 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | Protiva Biotherapeutics, Inc. (CA) | 2016-06-22 | — | — | EP | claimed |
| US-9365508-B2 | Aroyl thiourea derivatives | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2016-06-14 | — | — | US | claimed |
| WO-2015011633-A1 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | PROTIVA BIOTHERAPEUTICS, INC. (CA) | 2015-01-29 | — | — | WO | claimed |
| EP-1312616-B1 | Preparation of compounds of the kind polysaccharide betainates, obtained compounds, their use and the compositions containing them | OREAL (FR) | 2008-01-23 | — | — | EP | claimed |
| US-20070160557-A1 | Preparation of polysaccharide betainate type compounds, compounds obtained, their use and compositions comprising them | L'OREAL S.A. | 2007-07-12 | — | — | US | claimed |
| US-20030147818-A1 | Preparation of polysaccharide betainate type compounds, compounds obtained, their use and compositions comprising them | L'OREAL S.A. (FR) | 2003-08-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070160557-A1 | Preparation of polysaccharide betainate type compounds, compounds obtained, their use and compositions comprising them | ALG1, MANBA, FUT5 | KDM4A 3132/4885KDM4C 1078/4885KDM5A 2052/4885 |
| US-20030147818-A1 | Preparation of polysaccharide betainate type compounds, compounds obtained, their use and compositions comprising them | ALG1, MANBA, FUT5 | KDM4A 3182/4885KDM4C 1119/4885KDM5A 2206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.